MiNA raises £23M in first venture round 12 years after launch

After financing itself for 12 years via high-net-worth individuals and Sosei, London-based MiNA has tapped a traditional VC to lead its series A round to expand its pipeline of small activating RNA therapeutics. 

MiNA Therapeutics Ltd. raised £23 million ($29.4 million) in a series A led by healthtech and life sciences venture fund aMoon, with participation from undisclosed existing investors. ...